HUP0401910A3 - Novel use of substituted aminomethyl chromans and pharmaceutical compositions containing them - Google Patents
Novel use of substituted aminomethyl chromans and pharmaceutical compositions containing themInfo
- Publication number
- HUP0401910A3 HUP0401910A3 HU0401910A HUP0401910A HUP0401910A3 HU P0401910 A3 HUP0401910 A3 HU P0401910A3 HU 0401910 A HU0401910 A HU 0401910A HU P0401910 A HUP0401910 A HU P0401910A HU P0401910 A3 HUP0401910 A3 HU P0401910A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- novel use
- substituted aminomethyl
- aminomethyl chromans
- Prior art date
Links
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01122377 | 2001-09-19 | ||
PCT/EP2002/009001 WO2003024960A1 (en) | 2001-09-19 | 2002-08-12 | Novel use of substituted aminomethyl chromans |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0401910A2 HUP0401910A2 (hu) | 2005-01-28 |
HUP0401910A3 true HUP0401910A3 (en) | 2011-02-28 |
Family
ID=8178662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0401910A HUP0401910A3 (en) | 2001-09-19 | 2002-08-12 | Novel use of substituted aminomethyl chromans and pharmaceutical compositions containing them |
Country Status (25)
Country | Link |
---|---|
US (1) | US7618988B2 (hu) |
EP (1) | EP1427724B1 (hu) |
JP (1) | JP4615857B2 (hu) |
KR (1) | KR100912911B1 (hu) |
CN (1) | CN100338060C (hu) |
AR (1) | AR036677A1 (hu) |
AT (1) | ATE325120T1 (hu) |
AU (1) | AU2002331229B2 (hu) |
BR (1) | BR0212555A (hu) |
CA (1) | CA2460696C (hu) |
CY (1) | CY1105118T1 (hu) |
DE (1) | DE60211186T2 (hu) |
DK (1) | DK1427724T3 (hu) |
ES (1) | ES2262840T3 (hu) |
HU (1) | HUP0401910A3 (hu) |
MX (1) | MXPA04002492A (hu) |
MY (1) | MY128882A (hu) |
PE (1) | PE20030428A1 (hu) |
PL (1) | PL208787B1 (hu) |
PT (1) | PT1427724E (hu) |
RU (1) | RU2322443C2 (hu) |
SI (1) | SI1427724T1 (hu) |
TW (1) | TWI244391B (hu) |
WO (1) | WO2003024960A1 (hu) |
ZA (1) | ZA200402855B (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10318690B3 (de) * | 2003-04-24 | 2004-11-11 | Merck Patent Gmbh | Verfahren zur Herstellung von Nicotinaldehyden |
FR2978916B1 (fr) | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
US10561618B2 (en) * | 2012-04-18 | 2020-02-18 | Contera Pharma Aps | Orally available pharmaceutical formulation suitable for improved management of movement disorders |
FR3001894A1 (fr) | 2013-02-08 | 2014-08-15 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
CN109689036A (zh) | 2016-07-11 | 2019-04-26 | 康特拉医药公司 | 用于治疗早晨运动不能的脉冲药物输送系统 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5767132A (en) * | 1980-10-07 | 1982-04-23 | Nippon Steel Corp | Vertical type continuous annealing furnace having independently moving middle partition plate |
DE4135474A1 (de) * | 1991-10-28 | 1993-04-29 | Bayer Ag | 2-aminomethyl-chromane |
SI9300097B (en) * | 1992-02-27 | 2001-12-31 | Janssen Pharmaceutica Nv | (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines |
PL181385B1 (pl) * | 1993-08-19 | 2001-07-31 | Janssen Pharmaceutica Nv | Nowe pochodne dihydrobenzopiranu o wlasciwosciach naczyniozwezajacych, kompozycja farmaceutyczna i sposób wytwarzania pochodnych dihydrobenzopiranu PL PL PL PL PL PL |
DK0707007T3 (da) * | 1994-10-14 | 2002-03-18 | Merck Patent Gmbh | Amino(thio)etherderivater som CNS-aktive midler |
US5585388A (en) * | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
US5756521A (en) * | 1996-04-03 | 1998-05-26 | American Home Products Corporation | Chroman-2-ylmethylamino derivatives |
UA73981C2 (en) * | 2000-03-10 | 2005-10-17 | Merck Patent Gmbh | (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit |
-
2002
- 2002-08-12 PT PT02767363T patent/PT1427724E/pt unknown
- 2002-08-12 BR BR0212555-2A patent/BR0212555A/pt not_active IP Right Cessation
- 2002-08-12 DK DK02767363T patent/DK1427724T3/da active
- 2002-08-12 AU AU2002331229A patent/AU2002331229B2/en not_active Ceased
- 2002-08-12 CA CA2460696A patent/CA2460696C/en not_active Expired - Fee Related
- 2002-08-12 PL PL369684A patent/PL208787B1/pl not_active IP Right Cessation
- 2002-08-12 WO PCT/EP2002/009001 patent/WO2003024960A1/en active IP Right Grant
- 2002-08-12 CN CNB028183266A patent/CN100338060C/zh not_active Expired - Fee Related
- 2002-08-12 SI SI200230351T patent/SI1427724T1/sl unknown
- 2002-08-12 MX MXPA04002492A patent/MXPA04002492A/es active IP Right Grant
- 2002-08-12 DE DE60211186T patent/DE60211186T2/de not_active Expired - Lifetime
- 2002-08-12 HU HU0401910A patent/HUP0401910A3/hu unknown
- 2002-08-12 KR KR1020047002484A patent/KR100912911B1/ko not_active IP Right Cessation
- 2002-08-12 RU RU2004112190/15A patent/RU2322443C2/ru not_active IP Right Cessation
- 2002-08-12 US US10/489,960 patent/US7618988B2/en not_active Expired - Fee Related
- 2002-08-12 ES ES02767363T patent/ES2262840T3/es not_active Expired - Lifetime
- 2002-08-12 JP JP2003528807A patent/JP4615857B2/ja not_active Expired - Fee Related
- 2002-08-12 AT AT02767363T patent/ATE325120T1/de active
- 2002-08-12 EP EP02767363A patent/EP1427724B1/en not_active Expired - Lifetime
- 2002-08-13 TW TW091118183A patent/TWI244391B/zh not_active IP Right Cessation
- 2002-09-16 MY MYPI20023438A patent/MY128882A/en unknown
- 2002-09-17 PE PE2002000915A patent/PE20030428A1/es not_active Application Discontinuation
- 2002-09-18 AR ARP020103509A patent/AR036677A1/es unknown
-
2004
- 2004-04-15 ZA ZA200402855A patent/ZA200402855B/en unknown
-
2006
- 2006-07-28 CY CY20061101061T patent/CY1105118T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0401333A3 (en) | Spiropyrazole compounds and pharmaceutical compositions containing them | |
HUP0400974A3 (en) | Peptide-based compounds and pharmaceutical compositions containing them | |
IL192937A0 (en) | Pharmaceutical compositions containing beta-lapachone or derivatives or analogs thereof, and methods of using same | |
HUP0303325A3 (en) | Pharmaceutical salts and pharmaceutical compositions containing them | |
HUP0303193A3 (en) | Phthalayinone-piperidino-derivatives as pde4 inhibitors and pharmaceutical compositions containing them | |
IL173930A0 (en) | Pharmaceutical compositions containing forms of r-baclofen | |
IL166108A0 (en) | Novel compounds pharmaceutical compositions containing same and methods of use for same | |
HUP0400114A3 (en) | N-benzoyl-benzenesulfonamid derivatives as antitumor agents and pharmaceutical compositions containing them | |
HUP0304058A2 (hu) | Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
PL370855A1 (en) | N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation | |
HK1086485A1 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
HUP0400245A3 (en) | Somatostatin-dopamine chimeric analogs and pharmaceutical compositions containing them | |
HUP0400077A2 (hu) | Deutériumozott 3-piperidino-propiofenon és a vegyületeket tartalmazó gyógyszerekészítmények | |
HUP0402510A3 (en) | Nociceptin analogs and pharmaceutical compositions containing them | |
GB0108470D0 (en) | Pharmaceutical compositions and their use | |
HUP0400179A3 (en) | 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them | |
PL367128A1 (en) | Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors | |
HUP0401733A3 (en) | Cyclic amine-derivatives and pharmaceutical compositions containing them | |
GB0202900D0 (en) | Novel formulations of drugs | |
AU2003297840A8 (en) | Chemopreventive and therapeutic aspects of polyphenolic compositions and assays | |
HUP0400023A2 (hu) | Új heterociklusos származékok és gyógyászati alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
HUP0401204A3 (en) | Novel immunomodulating heterocondensated pyrazol-3-one derivatives and pharmaceutical compositions containing them | |
HUP0401644A3 (en) | Aminobenzoephenones, pharmaceutical compositions containing them and use thereof | |
HUP0303469A3 (en) | Phtalazinon-derivatives, their use and pharmaceutical compositions containing them | |
HUP0401862A3 (en) | Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |